SEC FORM
4
SEC Form 4
FORM 4 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
OMB APPROVAL |
OMB Number: |
3235-0287 |
Estimated average burden |
hours per response: |
0.5 |
|
|
|
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b). |
1. Name and Address of Reporting Person*
C/O SOFINNOVA INVESTMENTS, INC. |
3000 SAND HILL ROAD, BLDG. 4, SUITE 250 |
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
Vera Therapeutics, Inc.
[ VERA ]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
Director |
X |
10% Owner |
|
Officer (give title below) |
|
Other (specify below) |
|
|
3. Date of Earliest Transaction
(Month/Day/Year) 02/06/2023
|
4. If Amendment, Date of Original Filed
(Month/Day/Year)
|
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Form filed by One Reporting Person |
X |
Form filed by More than One Reporting Person |
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned |
1. Title of Security (Instr.
3)
|
2. Transaction Date
(Month/Day/Year) |
2A. Deemed Execution Date, if any
(Month/Day/Year) |
3. Transaction Code (Instr.
8)
|
4. Securities Acquired (A) or Disposed Of (D) (Instr.
3, 4 and 5)
|
5.
Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr.
3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr.
4)
|
7. Nature of Indirect Beneficial Ownership (Instr.
4)
|
Code |
V |
Amount |
(A) or (D) |
Price |
Class A Common Stock |
02/06/2023 |
|
P |
|
285,714 |
A |
$7
|
3,467,156 |
D
|
|
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivative Security (Instr.
3)
|
2. Conversion or Exercise Price of Derivative Security
|
3. Transaction Date
(Month/Day/Year) |
3A. Deemed Execution Date, if any
(Month/Day/Year) |
4. Transaction Code (Instr.
8)
|
5.
Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr.
3, 4 and 5)
|
6. Date Exercisable and Expiration Date
(Month/Day/Year) |
7. Title and Amount of Securities Underlying Derivative Security (Instr.
3 and 4)
|
8. Price of Derivative Security (Instr.
5)
|
9.
Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr.
4)
|
10. Ownership Form: Direct (D) or Indirect (I) (Instr.
4)
|
11. Nature of Indirect Beneficial Ownership (Instr.
4)
|
Code |
V |
(A) |
(D) |
Date Exercisable |
Expiration Date |
Title |
Amount or Number of Shares |
1. Name and Address of Reporting Person*
C/O SOFINNOVA INVESTMENTS, INC. |
3000 SAND HILL ROAD, BLDG. 4, SUITE 250 |
(Street)
|
1. Name and Address of Reporting Person*
C/O SOFINNOVA INVESTMENTS, INC. |
3000 SAND HILL ROAD, BLDG. 4, SUITE 250 |
(Street)
|
1. Name and Address of Reporting Person*
C/O SOFINNOVA INVESTMENTS, INC. |
3000 SAND HILL ROAD, BLDG. 4, SUITE 250 |
(Street)
|
1. Name and Address of Reporting Person*
C/O SOFINNOVA INVESTMENTS, INC. |
3000 SAND HILL ROAD, BLDG. 4, SUITE 250 |
(Street)
|
1. Name and Address of Reporting Person*
C/O SOFINNOVA INVESTMENTS, INC. |
3000 SAND HILL ROAD, BLDG. 4, SUITE 250 |
(Street)
|
Explanation of Responses: |
|
/s/ Nathalie Auber, as attorney-in-fact for Sofinnova Venture Partners X, L.P. |
02/08/2023 |
|
/s/ Nathalie Auber, as attorney-in-fact for Sofinnova Management X, L.P. |
02/08/2023 |
|
/s/ Nathalie Auber, as attorney-in-fact for James I. Healy |
02/08/2023 |
|
/s/ Nathalie Auber, as attorney-in-fact for Maha Katabi |
02/08/2023 |
|
/s/ Nathalie Auber, as attorney-in-fact for Sofinnova Management X-A, L.L.C. |
02/08/2023 |
|
** Signature of Reporting Person |
Date |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. |
* If the form is filed by more than one reporting person,
see
Instruction
4
(b)(v). |
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |
Exhibit 24
Power
of Attorney
Each of the undersigned entities
and individuals (collectively, the “Reporting Persons”) hereby authorizes and designates Sofinnova Management X-A, L.L.C.
or such other person or entity as is designated in writing by James I. Healy (the “Designated Filer”) as the beneficial owner
to prepare and file on behalf of such Reporting Person individually, or jointly together with the other Reporting Persons, any and all
reports, notices, communications and other documents (including, but not limited to, reports on Schedule 13D, Schedule 13G, Form 3, Form
4 and Form 5) that such Reporting Person may be required to file with the United States Securities and Exchange Commission pursuant to
the Securities Act of 1933, as amended (together with the implementing regulations thereto, the “Act”) and the Securities
Exchange Act of 1934, as amended (together with the implementing regulations thereto, the “Exchange Act”) (collectively, the
“Reports”) with respect to each Reporting Person’s ownership of, or transactions in, securities of any entity whose
securities are beneficially owned (directly or indirectly) by such Reporting Person (collectively, the “Companies”).
Each Reporting Person hereby
further authorizes and designates Nathalie Auber (the “Authorized Signatory”) to execute and file on behalf of such Reporting
Person the Reports and to perform any and all other acts, which in the opinion of the Designated Filer or Authorized Signatory may be
necessary or incidental to the performance of the foregoing powers herein granted.
The authority of the Designated
Filer and the Authorized Signatory under this Document with respect to each Reporting Person shall continue until such Reporting Person
is no longer required to file any Reports with respect to the Reporting Person’s ownership of, or transactions in, the securities
of the Companies, unless earlier revoked in writing. Each Reporting Person acknowledges that the Designated Filer and the Authorized Signatory
are not assuming any of the Reporting Person’s responsibilities to comply with the Act or the Exchange Act.
Date: January 2, 2023
SOFINNOVA VENTURE PARTNERS X, L.P., |
|
SOFINNOVA MANAGEMENT X-A, L.L.C., |
a Delaware Limited Partnership |
|
a Delaware Limited Liability Company |
|
|
|
By: |
SOFINNOVA MANAGEMENT X, L.P., |
|
By: |
/s/ James I. Healy |
|
a Delaware Limited Partnership |
|
|
James I. Healy |
|
Its General Partner |
|
|
Managing Member |
|
|
|
|
|
By: |
SOFINNOVA MANAGEMENT X-A, L.L.C., |
|
JAMES I. HEALY |
|
a Delaware Limited Liability Company |
|
|
|
|
Its General Partner |
|
By: |
/s/ James I. Healy |
|
|
|
|
James I. Healy |
By: |
/s/ James I. Healy |
|
|
|
|
James I. Healy |
|
MAHA KATABI |
|
Managing Member |
|
|
|
|
|
|
By: |
/s/ Maha Katabi |
SOFINNOVA MANAGEMENT X, L.P., |
|
|
Maha Katabi |
a Delaware Limited Partnership |
|
|
|
|
|
|
|
By: |
SOFINNOVA MANAGEMENT X-A, L.L.C., |
|
|
|
|
a Delaware Limited Liability Company |
|
|
|
|
Its General Partner |
|
|
|
|
|
|
|
|
By: |
/s/ James I. Healy |
|
|
|
|
James I. Healy |
|
|
|
|
Managing Member |
|
|
|